HARROW HEALTH, INC. Underwriting Agreements
8 Contracts & Agreements
- Underwriting Agreement between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein, dated July 18, 2023 (Filed With SEC on July 21, 2023)
- Notes Underwriting Agreement between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein, dated December 15, 2022 (Filed With SEC on December 16, 2022)
- Common Stock Underwriting Agreement between the Company and B. Riley Securities, Inc. dated December 13, 2022 (Filed With SEC on December 16, 2022)
- Underwriting Agreement, dated as of June 14, 2021, by and among the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein (Filed With SEC on June 17, 2021)
- Underwriting Agreement, dated as of April 15, 2021, by and between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein (Filed With SEC on April 20, 2021)
- Underwriting Agreement, dated as of April 8, 2021, by and among Harrow Health, Inc., Eton Pharmaceuticals, Inc. and National Securities Corporation (Filed With SEC on April 8, 2021)
- Underwriting Agreement, dated February 7, 2013, by and between the Company and MDB Capital Group, LLC (Filed With SEC on February 8, 2013)
- IMPRIMIS PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on October 26, 2012)
